Johnson & Johnson stock underperforms Thursday when compared to competitors

September 30, 2021

Shares of Johnson & Johnson
JNJ,
-1.54%

shed 1.54% to $161.50 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index
SPX,
-1.19%

falling 1.19% to 4,307.54 and Dow Jones Industrial Average
DJIA,
-1.59%

falling 1.59% to 33,843.92. Johnson & Johnson closed $18.42 below its 52-week high ($179.92), which the company achieved on August 20th.

The stock underperformed when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert.
RHHVF,
+1.11%

rose 1.11% to $365.52, Merck & Co. Inc.
MRK,
+0.03%

rose 0.03% to $75.11, and Pfizer Inc.
PFE,
-1.19%

fell 1.19% to $43.01. Trading volume (6.9 M) eclipsed its 50-day average volume of 5.5 M.


Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.